Company Overview
Snapshot
Founded in July 2014 by Irit Yaniv and Tamir Wolf, NitiNotes operates with 11–50 employees. The company has raised a total of $32.9M across 4 funding rounds from 5 investors. In December 2024, NitiNotes announced the closing of a $9.3M SAFE round.
Business overview
NitiNotes is a clinical-stage company developing a revolutionary treatment for obesity. Its flagship product, EndoZip, is an automated and operator-independent, minimally invasive robotic suturing system designed to simplify and speed up endoscopic gastroplasty procedures. This technology offers a widely available, minimally invasive, and effective solution for patients with obesity class I & II, for whom traditional bariatric surgery is not an option. NitiNotes operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics, serving the healthcare industry.
Strategic signal
In November 2025, NitiNotes received CE Mark approval for its EndoZip system, the first fully automated suturing system for endoscopic sleeve gastroplasty. This regulatory milestone is a significant validation of the company's technology, enabling commercialization in Europe and signaling readiness for broader market adoption and clinical impact in obesity treatment.
Log in to access full profile ›Company Intelligence Q&A
- What is NitiNotes' primary product?
- NitiNotes' primary product is EndoZip, an automated and operator-independent, minimally invasive robotic suturing system designed for endoscopic gastroplasty procedures to treat obesity.
- When did NitiNotes receive CE Mark approval for EndoZip?
- NitiNotes received CE Mark approval for its EndoZip system in November 2025, allowing for commercialization in Europe.
- What was the most recent funding event for NitiNotes?
- In December 2024, NitiNotes announced the closing of a $9.3M SAFE round. Investors included Elron Ventures and MTIP AG.
- What was the focus of the study published in GIE Journal in September 2024?
- In September 2024, a multicenter study on NitiNotes' EndoZip endoscopic suturing system for obesity treatment was published in the GIE Journal.
- When did NitiNotes announce its first commercial procedures in Spain?
- NitiNotes announced its first commercial EndoZip procedures in Spain in April 2026.